Literature DB >> 22039075

Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.

Irina Stepanov1, Lois Biener, Aleksandar Knezevich, Amy L Nyman, Robin Bliss, Joni Jensen, Stephen S Hecht, Dorothy K Hatsukami.   

Abstract

INTRODUCTION: Information on chemical composition of the new oral "spitless" smokeless tobacco products is scarce, and it is not clear whether there is some variability as a function of purchase place or time due to either unintended or intended manufacturing variations or other conditions.
METHODS: We analyzed tobacco-specific N-nitrosamines (TSNA) and nicotine in Marlboro Snus, Camel Snus, and dissolvable Camel products Orbs, Sticks, and Strips that were purchased in various regions of the country during the summer of 2010.
RESULTS: A total of 117 samples were received from different states representing six regions of the country. Levels of unprotonated nicotine in Marlboro Snus and Camel Snus varied significantly by regions, with the differences between the highest and the lowest average regional levels being relatively small in Marlboro Snus (∼1.3-fold) and large in Camel Snus (∼3-fold). Some regional variations in TSNA levels were also observed. Overall, Camel Snus had significantly higher TSNA levels than Marlboro Snus, and Camel Strips had the lowest TSNA levels among all novel products analyzed here. The amount of unprotonated nicotine in the dissolvable Camel products was comparable to the levels found in Marlboro Snus.
CONCLUSIONS: Our study demonstrates some regional variations in the levels of nicotine and TSNA in Marlboro and Camel novel smokeless tobacco products. Continued monitoring of this category of products is needed as the existing products are being test marketed and modified, and new products are being introduced. This information is particularly important given its relevance to Food and Drug Administration regulation of tobacco products.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039075      PMCID: PMC3281237          DOI: 10.1093/ntr/ntr209

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  24 in total

1.  Pharmacokinetics and pharmacodynamics of moist snuff in humans.

Authors:  R V Fant; J E Henningfield; R A Nelson; W B Pickworth
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Oral tobacco products: preference and effects among smokers.

Authors:  Dorothy K Hatsukami; Joni Jensen; Amanda Anderson; Berry Broadbent; Sharon Allen; Yan Zhang; Herb Severson
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

Review 3.  Smokeless tobacco use: harm reduction or induction approach?

Authors:  Dorothy K Hatsukami; Charlotte Lemmonds; Scott L Tomar
Journal:  Prev Med       Date:  2004-03       Impact factor: 4.018

Review 4.  Nitrosamines and human cancer: introduction and overview.

Authors:  P N Magee
Journal:  Eur J Cancer Prev       Date:  1996-09       Impact factor: 2.497

Review 5.  Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview.

Authors:  H Bartsch; B Spiegelhalder
Journal:  Eur J Cancer Prev       Date:  1996-09       Impact factor: 2.497

6.  Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.

Authors:  Patricia Richter; Francis W Spierto
Journal:  Nicotine Tob Res       Date:  2003-12       Impact factor: 4.244

7.  European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.

Authors:  C Bates; K Fagerström; M J Jarvis; M Kunze; A McNeill; L Ramström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

8.  Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff.

Authors:  S S Hecht; A Rivenson; J Braley; J DiBello; J D Adams; D Hoffmann
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 9.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

Authors:  S S Hecht; D Hoffmann
Journal:  Carcinogenesis       Date:  1988-06       Impact factor: 4.944

Review 10.  Epidemiological evidence for the role of nitroso compounds in human cancer.

Authors:  S Preston-Martin; P Correa
Journal:  Cancer Surv       Date:  1989
View more
  26 in total

1.  Transcriptome profiling in oral cavity and esophagus tissues from (S)-N'-nitrosonornicotine-treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis.

Authors:  Ali Khammanivong; Arunkumar Anandharaj; Xuemin Qian; Jung Min Song; Pramod Upadhyaya; Silvia Balbo; Dipankar Bandyopadhyay; Erin B Dickerson; Stephen S Hecht; Fekadu Kassie
Journal:  Mol Carcinog       Date:  2016-01-19       Impact factor: 4.784

2.  Comprehensive chemical characterization of Rapé tobacco products: Nicotine, un-ionized nicotine, tobacco-specific N'-nitrosamines, polycyclic aromatic hydrocarbons, and flavor constituents.

Authors:  Stephen B Stanfill; André Luiz Oliveira da Silva; Joseph G Lisko; Tameka S Lawler; Peter Kuklenyik; Robert E Tyx; Elizabeth H Peuchen; Patricia Richter; Clifford H Watson
Journal:  Food Chem Toxicol       Date:  2015-04-28       Impact factor: 6.023

3.  Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.

Authors:  Andrew B Seidenberg; Olalekan A Ayo-Yusuf; Vaughan W Rees
Journal:  Nicotine Tob Res       Date:  2018-01-05       Impact factor: 4.244

4.  Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.

Authors:  Jeffrey S Stein; A George Wilson; Mikhail N Koffarnus; Michael C Judd; Warren K Bickel
Journal:  Psychopharmacology (Berl)       Date:  2016-10-11       Impact factor: 4.530

5.  Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.

Authors:  Irina Stepanov; Lois Biener; Katrina Yershova; Amy L Nyman; Robin Bliss; Mark Parascandola; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-03-06       Impact factor: 4.244

6.  A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015.

Authors:  Jeffrey R Ammann; Katherine S Lovejoy; Matthew J Walters; Matthew R Holman
Journal:  J Agric Food Chem       Date:  2016-05-18       Impact factor: 5.279

7.  Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.

Authors:  Lois Biener; Amy L Nyman; Irina Stepanov; Dorothy Hatsukami
Journal:  Tob Control       Date:  2013-03-12       Impact factor: 7.552

8.  A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus.

Authors:  Jessica L Burris; Amy E Wahlquist; Anthony J Alberg; K Michael Cummings; Kevin M Gray; Elizabeth Garrett-Mayer; Matthew J Carpenter
Journal:  Addict Behav       Date:  2016-07-15       Impact factor: 3.913

9.  (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats.

Authors:  Silvia Balbo; Sandra James-Yi; Charles S Johnson; Michael G O'Sullivan; Irina Stepanov; Mingyao Wang; Dipankar Bandyopadhyay; Fekadu Kassie; Steven Carmella; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2013-05-13       Impact factor: 4.944

10.  Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products.

Authors:  Irina Stepanov; Katrina Yershova; Steven Carmella; Pramod Upadhyaya; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2012-12-03       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.